Immuno-Oncology Drugs Market Players – Trends, Opportunities, Strategies
The Global TBRC Immuno-Oncology Drugs Market report highlights the competitive landscape and tactics of key market players.
LONDON, March 23, 2022 /PRNewswire/ — Analysis of immuno-oncology drug industry growth shows companies have increased investment in immuno-oncology combination studies, with more than 200 mechanisms being investigated as PD combination partners -(L)1 or CTLA-4 and immuno-oncology actives represent about half of the pipelines of the top ten companies. Immunotherapy is one of the most active sectors for investors, with global funding of $96.9 billion in more than 1,400 companies. Hence, the growing investment in immuno-oncology is expected to drive the growth of the immuno-oncology market.
The size of the global immuno-oncology drugs market is expected to grow from $60.32 billion in 2021 for $70.59 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The market growth is mainly driven by businesses resuming operations and adapting to the new normal while recovering from the impact of COVID-19, which previously led to restrictive lockdown measures involving social distancing , remote working and closing business activities. which resulted in operational difficulties. The immuno-oncology market is expected to reach $120.37 billion in 2026 at a CAGR of 14.3%.
Request Free Sample Report of Immuno-Oncology Drugs Market
Competitive landscape of the global immuno-oncology drugs market
The global stem cell therapy market is concentrated and characterized by the presence of global immuno-oncology drug vendors. The top ten market competitors accounted for 96.84% of the total market in 2020. Major market players are F. Hoffmann-La Roche, Merck & Co, Bristol-Myers Squibb, Amgen Inc, and Johnson & Johnson.
Immuno-Oncology Drugs Market Trend – Increased Acquisition Activity
The focus areas of many companies in the immuno-oncology drug market have shifted towards increasing acquisitions to strengthen their market presence. The big players buy small or medium-sized companies to acquire new capacities or access new markets. Players are also acquiring competitors to restrain competition and increase market share.
Key Market Strategies
Strategies adopted by players in the immuno-oncology drugs market include emphasis on developing and launching novel combination drug therapies, enhancing immuno-oncology market presence through partnerships strategies, strengthening the immuno-oncology business through product licensing and acquisitions, and evaluating and advancing new technologies to change treatment models and deliver effective therapies in the field of immuno-oncology. immuno-oncology by creating strategic alliances.
Learn more about the Immuno-Oncology Drugs market report
Check out similar market reports:
Global Interventional Oncology Devices Market Report 2022 – By Product (Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE) ), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Soft Embolization), by type of cancer (liver cancer, kidney cancer, lung cancer, bone cancer, other types cancer) – Global market size, trends and forecasts 2022-2026
Global Oncology Drugs Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs , colorectal cancer drugs, stomach cancer drugs, kidney cancer drugs, brain tumor drugs, thyroid cancer drugs, skin cancer drugs, bladder cancer drugs, cervical cancer drugs, blood cancer drugs, others (Kaposi’s sarcoma, AIDS-related lymphoma, anal cancer, bone cancer, retinoblastoma, testicular cancer, hepatocellular (liver) cancer, mouth, neuroblastoma)), By distribution channel (hospital pharmacies, retail pharmacies/pharmacies), by route of administration (oral, parenteral), by classification Drugs (Branded Drugs, Generic Drugs), By Purchase Mode (Prescription Drugs, Over-the-Counter Drugs) – Global Market Size, Trends and Forecasts 2022-2026
Global Cellular Immunotherapy Market Report 2022 – By Therapy (Tumor Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) Therapy, Cell Therapy killers (NK)), by main indication (B-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma), by application (prostate cancer, breast cancer, Skin, Ovarian Cancer, Brain Tumor, Lung Cancer) – Market Size, Trends and Global Forecast 2022-2026
Want to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in business, market and consumer research. Located around the world, it has consultants specializing in a wide range of industries, including manufacturing, healthcare, financial services, chemicals and technology.
The most comprehensive database in the world
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and measures across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess gaps between supply and demand.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
E-mail: [email protected]
SOURCE The Trade Research Society